Showing posts with label shorter. Show all posts
Showing posts with label shorter. Show all posts
Wednesday, April 14, 2010
Abstract/full text - In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer
Conclusion
Taxane-based chemotherapy appears to promote tumor vascularization when administered every 3 weeks. A possible explanation is the secondary recovery of MVD in response to immediate cytotoxic and antiangiogenic effects of taxane-based chemotherapy. If confirmed prospectively, these findings favor shorter treatment intervals of taxane-based chemotherapy to counteract proangiogenic recovery.
add your opinions
short
,
shorter
,
taxane
,
treatment intervals
,
weeks
Subscribe to:
Posts
(
Atom
)